Abstract:Background: Lung cancer (LC) screening using low-dose computed tomography (CT) is recommended according to standard risk criteria or personalized risk calculators. Machine learning (ML) models that can predict disease risk are an emerging method in medicine for identifying hidden associations that are personally unique. Materials and methods: Using the tree-based pipeline optimization tool (TPOT), we developed an ML-based model, which is an ensemble of the Random Forest and XGboost models, based on known risk factors for LC, as part of a larger trial for ML prediction using electronic medical records and chest CT. We used data from patients with LC vs. controls (1:2) of patients aged ≥ 35 years. We developed a model for all LC patients as well as for patients with and without a smoking background. We included age, gender, body mass index (BMI), smoking history, socioeconomic status (SES), history of chronic obstructive pulmonary disease (COPD)/emphysema/chronic bronchitis (CB), interstitial lung disease (ILD)/pulmonary fibrosis (PF), and family history of LC. Results: Of the 4076 patients, 1428 (35 %) were in the LC group and 2648 (65 %) were in the control group. For the entire study population, our model achieved an accuracy of 71.2 %, with a sensitivity of 69 % and a positive predictive value (PPV) of 74 %. Higher accuracy was achieved for the two subgroups. An accuracy of 74.8 % (sensitivity 72 %, PPV 76 %) and 73.0 % (sensitivity 76 %, PPV 72 %) was achieved for the smoking and never-smoking cohorts, respectively. For the entire population and smoker cohort, COPD/emphysema/CB were the most important contributors, followed by BMI and age, while in the never-smoking cohort, BMI, age and SES were the most important contributors. Conclusion: Known risk factors for LC could be used in ML models to modestly predict LC. Further studies are needed to confirm these results in new patients and to improve them.

Correction: The efficacy of machine learning models in lung cancer risk prediction with explainability

The efficacy of machine learning models in lung cancer risk prediction with explainability

Retracted: Lung Cancer Classification and Prediction Using Machine Learning and Image Processing

Corrigendum: Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China

Retracted: Investigating the Lung Adenocarcinoma Stem Cell Biomarker Expressions Using Machine Learning Approaches

Correction: Early Prediction of Cardiac Arrest in the Intensive Care Unit Using Explainable Machine Learning: Retrospective Study

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Machine learning computational model to predict lung cancer using electronic medical records

Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care

Risk Prediction Models for Lung Cancer: Perspectives and Dissemination

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Predicting the risk of lung cancer using machine learning: A large study based on UK Biobank

Lung Cancer Risk Prediction with Machine Learning Models

Retracted: Construction and Validation of a Risk Prediction Model for Postoperative Urinary Retention in Lung Cancer Patients

RETRACTED: Liu et al. Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images. Cancers 2023, 15, 4044

Retracted: Performance Analysis of Deep Learning Models for Binary Classification of Cancer Gene Expression Data

Correction to: A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinoma

Author Correction: Long non-coding RNA expression patterns in lung tissues of chronic cigarette smoke induced COPD mouse model

Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)]

Publisher Correction: A Clonal Expression Biomarker Associates with Lung Cancer Mortality